Phase II Study to Compare MDCO-2010 vs Placebo and Tranexamic Acid in Patients Undergoing Cardiac Surgery
Status:
Terminated
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the dose response relationship regarding blood
loss, PK, PD and clinical outcomes of MDCO-2010 in comparison to placebo and tranexamic acid
in patients undergoing primary cardiac surgery with cardiopulmonary bypass. The aim of the
study is to define minimally effective dose of MDCO-2010.